| Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference |
Globe Newswire |
06/02 |
07:30 |
| Saia Provides April and May LTL Operating Data |
Globe Newswire |
06/02 |
07:30 |
| Watsco Completes Acquisition of Jackson Supply Company |
Globe Newswire |
06/02 |
07:30 |
| Tris Pharma Announces Presentation on The Complexity and Management of ADHD at Psych Congress Elevate 2026 |
Globe Newswire |
06/02 |
07:30 |
| Quantum Cyber Assumes Direct Manufacturing of Autonomous Drone; Expands BP United Agreement |
Globe Newswire |
06/02 |
07:30 |
| Exodus Named UFC's First Official Payments Partner |
Globe Newswire |
06/02 |
07:30 |
| TappAlpha Adds S&P 500® Naming to TSPY and Reduces Costs Through VOO Transition |
Globe Newswire |
06/02 |
07:30 |
| Gilat Presents Expanded Portfolio for Tactical Unmanned Platforms at Eurosatory 2026 |
Globe Newswire |
06/02 |
07:15 |
| CorVel Marks 35 Years on Nasdaq, Signals Next Phase of Long-Term Innovation and Growth |
Globe Newswire |
06/02 |
07:07 |
| XpressConnect™ PCIe® 6.0 and CXL 3.1 Retimers Address Latency and Signal‑Integrity Challenges in AI Data Centers |
Globe Newswire |
06/02 |
07:06 |
| First Connect Named to Inc.’s 2026 Best Workplaces List |
Globe Newswire |
06/02 |
07:01 |
| Victoria’s Secret & Co. Reports First Quarter 2026 Results |
Globe Newswire |
06/02 |
07:00 |
| Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies |
Globe Newswire |
06/02 |
07:00 |
| Can-Fite Reports Positive Clinical Observation in Phase 2a Pancreatic Cancer Study and Highlights Namodenoson’s RAS Signaling Inhibition Mechanism |
Globe Newswire |
06/02 |
07:00 |
| X-energy Submits Xe-100 HTGR for UK Generic Design Assessment |
Globe Newswire |
06/02 |
07:00 |
| Aya Gold & Silver Reports High-Grade Exploration Drill Results Near Pit Depth at Zgounder |
Globe Newswire |
06/02 |
07:00 |
| AlphaSense Named to Inc.’s 2026 Best Workplaces List |
Globe Newswire |
06/02 |
07:00 |
| SEED Therapeutics Highlights Clinical Advancement and Broad Oncology Potential of ST-01156, an RBM39 Molecular Glue Degrader in First-in-Human in Phase 1 Studies, at ASCO 2026 |
Globe Newswire |
06/02 |
07:00 |
| Opus Genetics to Host Virtual R&D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts |
Globe Newswire |
06/02 |
07:00 |
| Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096 |
Globe Newswire |
06/02 |
07:00 |
| MOXFIVE Named to Inc.’s 2026 Best Workplaces List |
Globe Newswire |
06/02 |
07:00 |
| Global Green HVAC Solutions Expands Across Los Angeles With a Modern Approach to Heating & Cooling Services |
Globe Newswire |
06/02 |
07:00 |
| ODDITY Tech Reports First Quarter 2026 Results, Makes Progress Toward Normalization |
Globe Newswire |
06/02 |
07:00 |
| Livium and Garage Composites Form Strategic Partnership to Deliver Unmatched Performance Solutions for Powersports Dealers |
Globe Newswire |
06/02 |
07:00 |
| Ocular Therapeutix™ to Host Investor Day on June 17, 2026 |
Globe Newswire |
06/02 |
07:00 |
